Ahmed Aljizeeri

555 total citations
47 papers, 318 citations indexed

About

Ahmed Aljizeeri is a scholar working on Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Ahmed Aljizeeri has authored 47 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 23 papers in Cardiology and Cardiovascular Medicine and 9 papers in Surgery. Recurrent topics in Ahmed Aljizeeri's work include Cardiac Imaging and Diagnostics (24 papers), Advanced MRI Techniques and Applications (12 papers) and Cardiovascular Function and Risk Factors (9 papers). Ahmed Aljizeeri is often cited by papers focused on Cardiac Imaging and Diagnostics (24 papers), Advanced MRI Techniques and Applications (12 papers) and Cardiovascular Function and Risk Factors (9 papers). Ahmed Aljizeeri collaborates with scholars based in Saudi Arabia, United States and Canada. Ahmed Aljizeeri's co-authors include Mouaz H. Al‐Mallah, Ahmed Alsaileek, Monvadi B. Srichai, Todd C. Villines, Matthias G. Friedrich, Ahmed Ibrahim Ahmed, Yoko Mikami, Mouhieddin Traboulsi, Todd J. Anderson and Nathan Dwyer and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Ahmed Aljizeeri

42 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed Aljizeeri Saudi Arabia 10 187 140 70 65 39 47 318
William L. Ballard United States 7 183 1.0× 108 0.8× 61 0.9× 174 2.7× 53 1.4× 8 327
S Braun Germany 11 53 0.3× 198 1.4× 61 0.9× 147 2.3× 33 0.8× 25 333
Yuan-Chang Liu Taiwan 7 182 1.0× 265 1.9× 50 0.7× 70 1.1× 47 1.2× 9 429
Tadamichi Sakuma Japan 10 264 1.4× 250 1.8× 135 1.9× 180 2.8× 25 0.6× 17 433
Enrico Favaretto Italy 10 153 0.8× 296 2.1× 23 0.3× 167 2.6× 84 2.2× 21 406
Robert Wilcox United Kingdom 13 278 1.5× 583 4.2× 46 0.7× 306 4.7× 84 2.2× 18 667
Nathan Dwyer Australia 17 67 0.4× 440 3.1× 59 0.8× 165 2.5× 34 0.9× 43 580
Ferdinando Loiacono Italy 8 158 0.8× 369 2.6× 38 0.5× 93 1.4× 24 0.6× 20 453
Tomoaki Natsukawa Japan 10 48 0.3× 126 0.9× 147 2.1× 145 2.2× 167 4.3× 16 390
Andrew J. Krainik United States 4 328 1.8× 301 2.1× 76 1.1× 115 1.8× 9 0.2× 6 507

Countries citing papers authored by Ahmed Aljizeeri

Since Specialization
Citations

This map shows the geographic impact of Ahmed Aljizeeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Aljizeeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Aljizeeri more than expected).

Fields of papers citing papers by Ahmed Aljizeeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Aljizeeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Aljizeeri. The network helps show where Ahmed Aljizeeri may publish in the future.

Co-authorship network of co-authors of Ahmed Aljizeeri

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Aljizeeri. A scholar is included among the top collaborators of Ahmed Aljizeeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Aljizeeri. Ahmed Aljizeeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Amjad, et al.. (2025). Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis. Biomedicines. 13(2). 490–490. 1 indexed citations
2.
Rifai, Mahmoud Al, et al.. (2025). Prognostic Value of PET-Derived Myocardial Flow Reserve in Patients With Very High Coronary Artery Calcium Score. Circulation Cardiovascular Imaging. 18(9). e018361–e018361. 1 indexed citations
3.
Al‐Mallah, Mouaz H., Firas Al Badarin, Frank M. Bengel, et al.. (2025). Potential worldwide impact of F-18 Flurpiridaz positron emission tomography myocardial perfusion imaging. Journal of Nuclear Cardiology. 45. 102167–102167. 2 indexed citations
4.
Badarin, Firas Al, et al.. (2024). Appraisal of amyloidosis imaging practices in the Middle East/North Africa (PYP-MENA). PubMed. 2(1). qyad025–qyad025. 1 indexed citations
5.
AlHabeeb, Waleed, Abdelfatah Elasfar, Abdulhalim Jamal Kinsara, et al.. (2024). A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus. Journal of the Saudi Heart Association. 36(4). 385–407. 1 indexed citations
6.
Rashid, Haroon, et al.. (2024). Evaluation of Noninvasive Diagnostic Techniques in Identifying Coronary Artery Disease: A Systematic Review. SHILAP Revista de lepidopterología. 25(3). 139–151. 1 indexed citations
7.
8.
Ahmed, Ahmed Ibrahim, Yushui Han, Talal Alnabelsi, et al.. (2021). The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review. Journal of Nuclear Cardiology. 28(4). 1545–1552. 12 indexed citations
9.
Aljizeeri, Ahmed, Ahmed Ibrahim Ahmed, Dalia Ahmed, et al.. (2021). Myocardial Flow Reserve and Coronary Calcification in Prognosis of Patients With Suspected Coronary Artery Disease. JACC. Cardiovascular imaging. 14(12). 2443–2452. 25 indexed citations
10.
Han, Yushui, Talal Alnabelsi, Tanushree Agrawal, et al.. (2021). The prognostic role of PET myocardial perfusion imaging in patients with cardiac sarcoidosis: a systematic review. European Heart Journal - Cardiovascular Imaging. 22(Supplement_3). 1 indexed citations
11.
Ahmed, Ahmed Ibrahim, Maan Malahfji, Yushui Han, et al.. (2021). LEFT VENTRICULAR MASS ON POSITRON EMISSION TOMOGRAPHY VALIDATION AGAINST CARDIOVASCULAR MAGNETIC RESONANCE. Journal of the American College of Cardiology. 77(18). 1407–1407. 1 indexed citations
12.
Aljizeeri, Ahmed, Gary R. Small, Saurabh Malhotra, et al.. (2020). Coronary artery disease in patients with human immunodeficiency virus infection. Journal of Nuclear Cardiology. 28(2). 510–530. 8 indexed citations
13.
Aljizeeri, Ahmed, Dalia Ahmed, Amjad Ahmed, et al.. (2019). ASSOCIATION BETWEEN RENAL FUNCTION AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH RENAL FAILURE AS MEASURED BY CORONARY FLOW RESERVE ON RUBIDIUM-82 PET. Journal of the American College of Cardiology. 73(9). 1564–1564.
14.
Aljizeeri, Ahmed, Dalia Ahmed, Amjad Ahmed, et al.. (2019). ARE PATIENTS WITH END-STAGE LIVER DISEASE MAXIMALLY VASODILATED? INSIGHTS FROM RUBIDIUM-82 PET DILATORY PERFUSION. Journal of the American College of Cardiology. 73(9). 1563–1563.
15.
Al‐Mallah, Mouaz H., et al.. (2018). Abstract 11557: Referral to Coronary Angiography Among Patients With Moderate or Severe Ischemia: Implications for the ISCHEMIA Trial. Circulation. 1 indexed citations
17.
Aljizeeri, Ahmed, et al.. (2017). Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!. Heart Failure Reviews. 22(4). 385–399. 18 indexed citations
18.
Al‐Mallah, Mouaz H., et al.. (2017). NON-INVASIVE CORONARY FLOW RESERVE PREDICTS INCIDENT ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 69(11). 1405–1405. 1 indexed citations
19.
Aljizeeri, Ahmed, et al.. (2013). Integrating anatomical and functional imaging for the assessment of coronary artery disease. Expert Review of Cardiovascular Therapy. 11(10). 1301–1310. 1 indexed citations
20.
Aljizeeri, Ahmed, Kenneth Gin, Marion E. Barnes, et al.. (2013). Atrial Remodeling in Newly Diagnosed Drug‐Naive Hypertensive Subjects. Echocardiography. 30(6). 627–633. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026